The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.
 
OTHER GROUP SITES

Email Alert
Email Alert
Company profiles
Company profiles
Add to Portfolio or Watchlist
Add to Portfolio or Watchlist

GWP  GW PHARMACEUTICALS PLC  ORD 0.1P
GW PHARM.  Currency GBX 
Company
Market
Market




 Page 2 of 2

Previous | 1 | 2 |

Time/Date Code Headline Source Impact
09:30 19-Feb-2013 GWP Blocklisting Interim Review RNS +0.18% Up
11:44 21-Jan-2013 GWP Result of AGM RNS -3.04% Down
10:04 04-Dec-2012 GWP Director/PDMR Shareholding RNS -4.26% Down
14:54 30-Nov-2012 GWP Director/PDMR Shareholding RNS -3.42% Down
14:50 30-Nov-2012 GWP Director/PDMR Shareholding RNS -3.42% Down
07:00 28-Nov-2012 GWP PhIIa Study Identifies New Anti-Diabetic Treatment RNS -1.75% Down
07:00 28-Nov-2012 GWP Preliminary Results RNS -1.75% Down
11:31 22-Nov-2012 GWP Notice of Results RNS -2.10% Down
07:00 12-Nov-2012 GWP GW to Present at Lazard Healthcare Conference RNS +2.20% Up
07:00 12-Oct-2012 GWP Positive German Sativex Data Presented at ECTRIMS RNS -1.09% Down
07:00 01-Oct-2012 GWP Appointment of Chief Operating Officer RNS -1.82% Down
07:00 13-Sep-2012 GWP Publication of New Epilepsy Data RNS +8.11% Up
12:14 20-Aug-2012 GWP Director/PDMR Shareholding RNS +1.21% Up
16:04 17-Aug-2012 GWP Blocklisting Interim Review RNS +3.92% Up
07:00 22-Jun-2012 GWP German GBA establishes positive benefit of Sativex RNS -6.19% Down

 Page 2 of 2

Previous | 1 | 2 |


GW PHARM. - News Analysis

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds